Showing results (851-860 of 941) with videos related to
Sort By:
Pageof 95
Diabetes & Vascular Disease Research|April 13, 2010
Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitusMaike Anderssohn, Edzard Schwedhelm, Nicole Lüneburg, et al.Diabetes & Vascular Disease Research|April 13, 2010
The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant ratsSubramanyam N Murthy, Rose-Claire St Hilaire, David B Casey, et al.Diabetes & Vascular Disease Research|April 13, 2010
Adherence to vascular protection drugs in diabetic patients in Quebec: a population-based analysisShabnam Asghari, Josiane Courteau, Catherine Drouin, et al.Diabetes & Vascular Disease Research|April 7, 2010
Long-term effect of metformin on metabolic parameters in the polycystic ovary syndromeKai I Cheang, Jessica M Huszar, Al M Best, et al.Diabetes & Vascular Disease Research|April 7, 2010
Coadministration of muraglitazar plus glyburide: improvement of glycaemic and lipid profiles in patients with type 2 diabetesCindy J Rubin, Veerle De Pril, Fred T FiedorekDiabetes & Vascular Disease Research|April 7, 2010
Metabolic syndrome, endothelial function and lifestyle modificationKunihiko Aizawa, J Kevin Shoemaker, Tom J Overend, et al.Diabetes & Vascular Disease Research|April 7, 2010
Raised natriuretic peptides, big-endothelin-1 and improved beta-cell function in type 2 diabetic males with hyperuricaemiaMichel P Hermans, Sylvie A Ahn, Michel F RousseauDiabetes & Vascular Disease Research|April 7, 2010
Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosisYun Hu, Guoyu Tong, Wei Xu, et al.Diabetes & Vascular Disease Research|April 7, 2010
Lifestyle risk factors for atherosclerosis in adults with type 1 diabetesFranziska K Bishop, David M Maahs, Janet K Snell-Bergeon, et al.Diabetes & Vascular Disease Research|April 7, 2010
The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery diseaseMartin K Rutter, Richard W NestoPageof 95